Glenmark Pharmaceuticals
-
Glenmark Pharma, OMRON Healthcare India team up to combat hypertension
Aims to reach out to around 92,000 Healthcare Professionals (HCPs) and around ten crore Indians in one year Glenmark Pharmaceuticals…
Read More » -
Glenmark Pharmaceuticals hosts drug discovery workshop for Sion Hospital students
The event had over 3000 MBBS student delegates from across the country and around the world Glenmark Pharmaceuticals, an integrated,…
Read More » -
Glenmark Pharma becomes part of Science Based Targets initiative
Sets Green House Gas emission targets for FY 2035 Glenmark Pharmaceuticals has joined the esteemed Science Based Targets initiative (SBTi)…
Read More » -
Glenmark receives US FDA nod for GRC 54276 to treat advanced solid tumours and lymphomas
GRC 54276 is an orally available, small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor Glenmark Specialty, the subsidiary of Glenmark Pharmaceuticals,…
Read More » -
Glenmark in exclusive distribution agreement with Cediprof
Glenmark expects to commence distribution of the product in the US during the second half of 2023 Glenmark Pharmaceuticals, USA…
Read More » -
Glenmark launches AKYNZEO IV for prevention of chemotherapy-induced nausea and vomiting
AKYNZEO IV, a fixed-dose combination of fosnetupitant (235mg) and palonosetron(0.25mg), will be available as a single-dose, ready-to-dilute IV injection Glenmark…
Read More » -
Glenmark launches cardiovascular drugs Sacubitril + Valsartan in India
The launch of Sacubitril + Valsartan has been launched under the brand name Sacu V Glenmark Pharmaceuticals, an innovation‐driven, global…
Read More » -
Glenmark launches Triple FDC of Teneligliptin + Pioglitazone + Metformin diabetes drug
The novel triple FDC will help improve glycemic control among adults with High HbA1c and high insulin resistance, those whose…
Read More » -
JB Pharma to acquire entire Razel franchise for Rs 314 crores
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy JB…
Read More » -
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in US
RYALTRIS is the only fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular in…
Read More »
